Results 51 to 60 of about 540,756 (159)
Standard melanoma-associated markers do not identify the MM127 metastatic melanoma cell line [PDF]
Reliable identification of different melanoma cell lines is important for many aspects of melanoma\ud research. Common markers used to identify melanoma cell lines include: S100; HMB-45; and Melan-A.\ud We explore the expression of these three markers in
Simpson, Matthew J. +4 more
core +1 more source
Measles virus causes immunogenic cell death in human melanoma [PDF]
NoOncolytic viruses (OV) are promising treatments for cancer, with several currently undergoing testing in randomised clinical trials. Measles virus (MV) has not yet been tested in models of human melanoma.
Russell, S +44 more
core +1 more source
Evolving Pharmacotherapies for the Treatment of Metastatic Melanoma
Metastatic melanoma remains a difficult disease to treat, and long term survivors are rare. Over the past few years, however, breakthroughs in both immunotherapy as well as targeted agents have had a tremendous impact on patients diagnosed with this ...
April K.S. Salama
core +1 more source
Mast cells impair melanoma cell homing and metastasis by inhibiting HMGA1 secretion. [PDF]
Metastatic disease is the major cause of death from cancer. From the primary tumour, cells remotely prepare the environment of the future metastatic sites by secreted factors and extracellular vesicles.
Hergueta-Redondo, Marta +12 more
core +1 more source
Skin cutaneous melanoma (SKCM) is the major cause of death for skin cancer patients, its high metastasis often leads to poor prognosis of patients with malignant melanoma.
Si Cheng +7 more
doaj +1 more source
Proton beam radiotherapy in the management of uveal melanoma: clinical experience in Scotland [PDF]
<p>Aim: To evaluate proton-beam radiotherapy (PBRT) in the management of uveal melanoma in Scotland.</p> <p>Methods: A retrospective review was undertaken on all patients receiving PBRT for uveal melanoma (1994–2005).
McConnachie, A. +9 more
core +1 more source
Background/Objectives: Intestinal malignant melanoma is a rare entity, most commonly presenting as metastatic disease from a cutaneous primary source.
Alexandra Caziuc +4 more
doaj +1 more source
By the recent introduction of molecular targeting drugs against BRAF mutation and immune checkpoint inhibitors, the prognosis of patients with melanoma in advanced stage is now improving, but still in the minority.
W. Omata +5 more
doaj +1 more source
Metastatic melanoma has long been considered to have a very poor prognosis and to be chemo-resistant. However, a subgroup of patients with metastatic melanoma presents remarkable responses to chemotherapeutic agents, even in the absence of a response to ...
Aurélien Simon +2 more
doaj +1 more source
Phase 1 study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers [PDF]
We assessed the safety, tolerability and efficacy of the immunomodulatory drug, CC-5013 (REVIMID(TM)), in the treatment of patients with metastatic malignant melanoma and other advanced cancers.
Muller, G.W. +35 more
core +1 more source

